| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 268 |
| 1 | ETANERCEPT | 52 |
| 2 | ADALIMUMAB | 40 |
| 3 | ERGOCALCIFEROL | 29 |
| 4 | BORTEZOMIB | 23 |
| 5 | SARILUMAB | 23 |
| 6 | INTERFERON BETA-1A | 21 |
| 7 | ALBUTEROL SULFATE | 18 |
| 8 | GLATIRAMER ACETATE | 14 |
| 9 | PREDNISONE | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BENZOCAINE 10% | 1 | 0.0385 |
| 1 | FERRIC OXIDE RED, ZINC OXIDE, AND PRAMOXINE HYDROCHLORIDE | 1 | 0.0152 |
| 2 | COLESEVELAM HCL | 1 | 0.0135 |
| 3 | EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) | 4 | 0.0082 |
| 4 | LEVAMLODIPINE | 1 | 0.0080 |
| 5 | RILONACEPT | 6 | 0.0052 |
| 6 | COSYNTROPIN | 1 | 0.0045 |
| 7 | CAMPHOR, EUCALYPTUS OIL, MENTHOL | 1 | 0.0043 |
| 8 | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, OXYBENZONE | 1 | 0.0042 |
| 9 | FEXOFENADINE HYDROCHLORIDE TABLETS | 1 | 0.0039 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-4 Receptor alpha Antagonist [EPC] | 268 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 55 |
| 2 | Corticosteroid [EPC] | 38 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 30 |
| 4 | Provitamin D2 Compound [EPC] | 29 |
| 5 | Benzodiazepine [EPC] | 26 |
| 6 | Interferon beta [EPC] | 26 |
| 7 | Interleukin-6 Receptor Antagonist [EPC] | 23 |
| 8 | Proteasome Inhibitor [EPC] | 23 |
| 9 | PCSK9 Inhibitor [EPC] | 21 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adrenocorticotropic Hormone [EPC] | 3 | 0.0034 |
| 1 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 2 | Endoglycosidase [EPC] | 4 | 0.0022 |
| 3 | Cytolytic Agent [EPC] | 5 | 0.0021 |
| 4 | Provitamin D2 Compound [EPC] | 29 | 0.0010 |
| 5 | Neonatal Fc Receptor Blocker [EPC] | 4 | 0.0009 |
| 6 | PCSK9 Inhibitor [EPC] | 21 | 0.0008 |
| 7 | Interleukin-13 Antagonist [EPC] | 4 | 0.0006 |
| 8 | Interleukin-4 Receptor alpha Antagonist [EPC] | 268 | 0.0005 |
| 9 | Aryl Hydrocarbon Receptor Agonist [EPC] | 1 | 0.0005 |